Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Giant Cell Arteritis Challenging to Diagnose, Manage

Sebastian Unizony, MD, and John H. Stone, MD, MPH  |  Issue: March 2015  |  March 1, 2015

Moreover, the detection of temporal artery abnormalities by physical examination is highly dependent on the skill of the examiner, and up to one-third of patients with biopsy-proven GCA in the temporal arteries have normal temporal artery findings on physical examination.

In addition, up to 10% of the GCA patients have either normal inflammatory markers or falsely negative temporal artery biopsies, even before the initiation of corticosteroid (CS) therapy.4,5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 1: Temporal Artery Biopsy in GCA
Low-magnification image showing a chronic inflammatory process composed of lymphocytes, macrophages and giant cells infiltrating the temporal artery wall in a patient with GCA.

Non-Invasive Vascular Imaging

Since the development of the ACR classification criteria for GCA, cross-sectional imaging has assumed an increasing role in the evaluation of patients with large-vessel vasculitis. Current radiologic modalities, which include magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), computed tomography angiography (CTA), positron emission tomography (PET) and combinations of those (e.g., PET/CT, PET/CTA or PET/MRI/MRA) (see Figure 2), can detect mural and luminal vascular abnormalities indicative of active or previous “vasculitic damage” to elastic and muscular arteries. These abnormalities include arterial wall thickening, edema or contrast/radioactive isotope uptake, as well as segments of narrowing, occlusion or aneurysmal dilatation. For example, vascular imaging may suggest GCA in elderly patients presenting with limb claudication and increased inflammatory markers in the absence of cranial symptoms, polymyalgia rheumatica or temporal artery abnormalities. In addition, vascular radiology is useful in individuals with known GCA who develop thoracic aortic aneurysms and, therefore, need longitudinal image surveillance to plan the timing of surgery to prevent aortic rupture.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Depending on the clinical setting (e.g., new-onset vs. long-standing disease) and the tech­nology used, between 10% and 90% of all GCA patients have radiographic evidence of disease in the aorta and its primary branches. In early stages of the disorder, arterial wall thickening and/or mural contrast enhancement is demonstrated in up to 70% of subjects by CTA.6

Acute arteritic lesions are also seen by MRA/MRI in more than 90% of cases presenting with fever of unknown origin.7 On follow-up, chronic stenosis and/or dilatations of the thoracic aorta, subclavian and axillary arteries are frequently detected by MRA.8

On the other hand, nearly 80% of GCA patients have long segments of increased linear 18F-fluorodeoxy­glucose (18F-FDG) uptake by PET in at least one vascular territory at diagnosis.9 The subclavian arteries are involved in three out of four cases and the aorta in almost half of the individuals.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsResearch RheumVasculitis Tagged with:DiagnosisGiant Cell ArteritisResearchrheumatologyTreatmentVasculitis

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Case Report: Giant Cell Arteritis-Related Stroke

    September 10, 2023

    Thromboembolic events are major contributors to the morbidity and mortality of patients with giant cell arteritis (GCA), but little is known about how GCA may increase the risk of ischemic strokes. GCA-related stroke is described as an ischemic cerebral infarct occurring within three to four weeks of GCA diagnosis and treatment. It occurs in 3–7%…

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    November 14, 2021

    Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences